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Abstract: 
β-Endorphin (BEP) has been implicated in the analgesic response to transcutaneous electrical 
nerve stimulation (TENS). The anterior pituitary gland is a source of β-endorphin which shares the 
prohormone proopiomelanocortin (POMC) with adrenocorticotropin (ACTH). Current theory 
proposes that the stimulation-induced breakdown of POMC results in ACTH release with a 
subsequent elevation in blood cortisol levels. The purpose of this study was to determine the 
potential application and mechanism of TENS as an anti-inflammatory agent. Eight female subjects 
received low frequency, 300 μsec pulse width TENS at four sites associated with relief of upper 
arm pain once when pain free and again while experiencing delayed onset muscle soreness (DOMS) 
of the elbow flexor muscle group. Blood samples were withdrawn 15 and 1 minute before and 1, 
20, and 40 minutes after treatment. Serum was analyzed for cortisol by radioimmunoassay. 
TENS treatment failed to elevate serum cortisol concentration, but there was a significant 
reduction in perception of pain ( p < 0.05) and an improvement in range of elbow extension (p 
< 0.05) when subjects were treated for DOMS. These results suggest that the anterior pituitary is 
not a source of BEP in TENS-induced analgesia. 
 
Article: 
The identification of endogenous opioids (17) and the isolation of β-endorphin (BEP) in the 
1970s led to new models of stimulation-induced analgesia. Castel (5) proposed that 
transcutaneous electrical nerve stimulation (TENS) with selected parameters of low frequency 
and long pulse duration, would result in the release of BEP from the anterior pituitary gland. 
BEP shares the pro hormone proopiomelanocortin (POMC) with adrenocorticotropin (ACTH) 
(14, 20, 31) and ACTH subsequently stimulates the synthesis and release of cortisol from the 
adrenal cortex (15, 31). 
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Cortisol is the most prevalent glucocorticoid in man (15). It stimulates gluconeogenesis, pro-
motes glucose utilization, protein synthesis, fatty acid mobilization, and suppresses acute and 
chronic inflammatory responses (2). The purpose of this investigation was to measure serum 
cortisol concentrations in response to a 30-minute TENS treatment (pulse rate = 2/sec, pulse 
width = 300 μsec, intensity adjusted to maximum tolerance) and to determine the potential 
application of TENS as an anti-inflammatory modality. 
 
METHODS 
Eight female subjects (age = 21.8 ± 1.9 years, height 166.1 ± 5.3 cm, weight = 58.1 ± 7.1 
100 kg) were recruited to participate and gave their informed consent in compliance with the 
University of Virginia's Human Investigation Committee guidelines. None were currently 
participating in weight training programs or intercollegiate athletics. Each subject participated in 
an orientation session to become familiar with the investigation protocol and TENS. 
 
To control for the diurnal variation in cortisol release, subjects were scheduled to return to the 
laboratory in pairs (two subjects each evening) at 1700 h. Following skin preparation, a 
heparinized needle (21 g) was inserted into the anticubital vein of the dominant arm. The 
subjects rested quietly or read for 30 minutes at which time a 5 ml sample was withdrawn. The 
skin was prepared and round, 10 mm diameter electrodes were placed at four sites (TH 14, LI 11, 
LI 13, LI 14) associated with pain control in the upper arm (33). The subjects rested for 15 
minutes after the first sample, when a second 5 ml sample was withdrawn and the TENS 
treatment started. TENS was applied by a NeuroTech NT-16 (NeuroTech, North Andover, MA) 
stimulator set to deliver two pulses per second with a pulse width of 300 ysec and the intensity 
adjusted to maximal tolerance for 30 minutes (5, 22). Blood samples were withdrawn 1, 20, and 
40 minutes after treatment, while the subjects remained at rest. Serum was separated from the 
formed elements by centrifugation and frozen at —10°C. 
 
Subjects returned 5 days after the first treatment session. A standard goniometer was used to 
assess elbow joint range of motion. All had normal elbow extension (> —5°) bilaterally and 
denied having soreness in the upper arms before exercise. Delayed onset muscle soreness 
(DOMS) was induced in the elbow flexors through repeated eccentric muscle contractions. Each 
subject initially lowered a 25-lb dumbbell from full elbow flexion to complete extension over 3 
sec. When subjects were unable to control the weight for the full 3 sec, the weight was decreased 
to 20 lbs. This process continued in 5-lb decrements until the subject could not control 5 lbs or 
had completed 40 repetitions with 5 lbs. Elbow flexion was done by laboratory personnel to 
avoid fatigue due to concentric lifting. Subjects were asked to refrain from using analgesic/anti-
inflammatory medications, receiving physical therapy or participating in vigorous upper arm 
exercise for 48 hours. 
 
Forty-eight hours after the exercise bout subjects returned for a second treatment session. The 
session was identical to the first except that elbow extension was assessed with a standard 
goniometer and perceived pain was assessed with the pain scale described by Talag (30) (Fig. 1). 
Blood samples were withdrawn at these times. Subjects were also questioned regarding their 
compliance with our instructions. All subjects denied using medications, receiving therapy, or 




Figure 1: Pain scale described by Talag (30). 
 
Serum samples were analyzed by a solid phase cortisol radioimmunoassay (Cort-A-Count 
Cortisol, Diagnostic Products Corp., Los Angeles, CA) in a single assay run. Intraassay 
variability was less than 11% in the range tested. 
 
RESULTS 
Serum cortisol concentration did not rise following low frequency, long pulse width TENS 
(Table 1). Only one subject had post-treatment cortisol concentrations above her pre-treatment 
level. This elevation was small (188 nmo1/1 at 1, 103 nmol/I at 20, and 52.4 nmo1/1 at 40 
minutes after treatment) and occurred only in the pain free state. Five subjects had cortisol levels 
elevated above normal values for the time of day during the first treatment session. Four had 
similar levels during their second treatment. 
 
There was a significant decrease in perceived pain following treatment when subjects were ex-
periencing DOMS [F(4,28) = 4.10, p = 0.01] (Table 2). There was also a significant increase in 
elbow extension after treatment (Table 3) [F(2,28) = 1 0.82, p < 0.01]. Post hoc Tukey tests 
revealed that elbow extension immediately following treatment was significantly greater (p < 
0.05) than at baseline and that at 20 and 40 minutes after treatment elbow extension was 
significantly greater (p < 0.05) than before treatment. 
 
DISCUSSION 
We found that TENS treatment decreased perceived pain and increased elbow extension range of 
motion, but that cortisol levels did not rise. These data are not consistent with the hypothesis that 
low frequency, long pulse width TENS-induced analgesia is mediated by BEP released from the 






TABLE 1: Serum cortisol levels (mol/l) before and after treatment in a pain free condition and 
during delayed onset muscle soreness  






1 min after 20 min 
after 
40 min after 
Pain free 749 ±  370 701 i t  398 646 ± 387 621 ± 434 540 ±  353 
With DOMS 551 ±  342 573 ±  426 504 ± 345 462 ± 306 404 ±- 261 
 
The failure to elevate serum cortisol concentration in our subjects indicates that neither PMOC 
nor ACTH were released from the anterior pituitary. The results suggest that the treatment 
effects were not due to a release of BEP from the anterior pituitary. These findings are in 
agreement with previous studies that reported TENS analgesia was not reversed by naloxone 
hydrochloride (1, 7, 13, 24, 25, 32), although none used stimulation parameters identical to ours. 
Our results do not rule out BEP as an active agent in TENS induced analgesia. However, if BEP 
is an active agent in TENS-induced analgesia, the source is probably within the brain since BEP 
does not easily cross the blood-brain barrier (3, 31). 
 
A previous study reported that TENS treatment altered perceived pain in subjects following 
DOMS, but did not significantly alter elbow extension (11). That study employed a bipolar 
electrode placement over the site of greatest tenderness and the musculotendinous junction of the 
biceps with large (250 sq cm) electrodes. In this study, the stimulation of acupuncture sites with 
smaller electrodes yielded different results. This conflict is not easily explained, but is suggestive 
of multiple analgesic mechanisms as proposed by others (8) and illustrates the need for continued 
search for the mechanism(s) of TENS-induced analgesia. 
 
TABLE 2: Perceived pain in the upper arm as measured by the Talag  
pain scale at each measurement time (mean ± SD) 
 
 
Several investigators have implicated endogenous opioids in electro-acupuncture (EA) and 
TENS induced analgesia using naloxone hydrochloride challenge studies (6, 16, 23, 26, 28), and 
direct measurement of BEP levels in plasma (12, 21) and cerebrospinal fluid (10, 27, 29). in 
1979 Castel (5) proposed that the anterior pituitary gland was an important source of BEP in low 
frequency, long pulse width TENS induced analgesia. Elevated levels of ACTH in man (21) and 
cortisol in horses (4, 9) and rabbits (18, 19) have been reported following low frequency EA. 
 
The elevation of ACTH and cortisol concentrations in animals following EA may represent a 
generalized stress response rather than a specific response to electrotherapy (7). Animal subjects 
are unable to anticipate the experimental treatment and would respond to the stress of EA only 
after the initiation of treatment. The subjects in this study were aware of the experimental pro-
cedure and the discomfort of venipuncture and low frequency, long pulse width TENS. The ex-
perimental procedure and treatment may have represented a stressor sufficient to elicit an ele-
vation in ACTH and cortisol concentrations for some subjects. Physical and psychological stres-
sors have been reported to elevate blood cortisol levels 20-fold (15); however, the cortisol levels 
were within 5-fold of normal values in all subjects. In nearly one-half of the trials (7 out of 16) 
serum cortisol levels were within normal limits for the time of day. 
 
A control group was not employed because we could not justify inducing soreness simply to 
document the normal course of DOMS in a study directed at measuring blood cortisol responses. 
Previous work reported that DOMS increases for about 48 hours, decreases slightly (<0.25 on the 
pain scale) between 48 and 72 hours, and gradually disappears over 5-7 days (30). Other factors, 
such as a placebo response or the passage of time, cannot be ruled out as contributing to the 
decrease in pain and increase in elbow extension. We believe that the decrease in reported pain 
and increase in elbow extension following TENS while subjects had DOMS was primarily due to 
the TENS treatment. 
 
TABLE 3: Elbow extension (degrees) at each measurement time (mean ± SD) 
 
 15 min before 
—20.9 ± 12.7 
 1 non before 
— 1 9 . 75  12 8  
  1 min after 20 min after 40 min after 
—8.1 ± 7.8t          —11.5 ± 10.5* —8.1 ± 8.0-r 
* Significantly different from 15 minutes before treatment measure. 
t Significantly different < 0.05) from both pre-treatment measures. 
 
CONCLUSION 
The low frequency, long pulse duration TENS treatment applied in this study resulted in de-
creased perceived pain and increased elbow extension range of motion but did not increase 
serum cortisol concentration. These data do not support TENS as an anti-inflammatory agent. 
Furthermore, these data are not consistent with the hypothesis that low frequency, long pulse 
duration TENS-induced analgesia is mediated by BEP released from the anterior pituitary gland. 
These results do not rule out BEP as an active agent in low frequency, long pulse width TENS-
induced analgesia. However, if BEP is active in TENS- induced analgesia, the source is probably 
within the blood brain barrier. 
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